Manipal Health Enterprises Limited

Manipal Health Enterprises Limited (MANIPALHOS) is a mid-cap Healthcare company valued at ₹85,105 crore operating in Hospital on the NSE and BSE.

Recent price move

Manipal Health Enterprises Limited last traded at ₹658.5, modestly up 1.82% on the day.

Recent developments

On 2026-08-05, the company's stock traded at ₹651, a 11% premium over the IPO price of ₹590. On 2026-08-07, the IPO was subscribed 5x on the closing day. On 2026-11-03, the IPO's GMP, price band, and review were detailed.

Financial performance

The company's business is growing, with annual revenue rising 15.5% year-over-year. However, net profit fell 19.6% annually, and the net profit margin dropped 5.2 percentage points to 12.0%. The latest quarter saw revenue surge 277.8% compared to the same quarter a year earlier, while net profit jumped 93.2%, indicating strong recent performance.

Valuation multiples

The stock trades at 180.9 times earnings, a premium to the Healthcare median of 32.0, 5.87 times book value.

Things to watch

The company's net profit margin has declined significantly, falling 5.2 percentage points to 12.0%. The stock is 20.7% below its 52-week high. The company has not paid dividends despite reporting profits.

Where it stands

The company is showing strong recent growth, with the latest quarter revenue and net profit both rising sharply. However, the net profit margin remains low, and the stock is trading below its 52-week high. The most significant figure is the latest quarter net profit, which rose 93.2% compared to the same quarter a year earlier.

Summarised by DocStoX's model on 2026-11-07 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.